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Purpose: Fatigue is the third most common “extraintestinal” complaint of patients with irritable bowel
syndrome (IBS), but it is still poorly understood. This study aimed to review characteristics of IBS-
associated fatigue and to examine pooled frequency, severity of fatigue, and correlations of related
factors with fatigue in IBS via meta-analyses.
Methods: Publications were searched in eight databases from 1995 to 2014. Random effects meta-
analyses were applied with standard error, weighted effect size, and correlation-based measure of ef-
fect size.
Results: Twenty-four studies were included in systematic review. Seventeen studies were used for meta-
analyses (2 studies were excluded in the frequency of fatigue analysis due to data unavailability). Using
“tiredness” to deﬁne fatigue, and Fatigue Impact Scale to assess fatigue were the most frequently used
across the studies. Gastrointestinal symptoms, psychological distress, and health-related quality of life
were the most common correlates with fatigue. The pooled frequency of fatigue was 54.2% [95% conﬁ-
dence interval (38.5, 69.4)]. Metaregression on the frequency of fatigue showed positive and signiﬁcant
relations with tertiary care settings, female sex, and younger age. There was a negatively moderate
relationship between the severity of fatigue and health-related quality of life score (correlation-based
measure of effect size: e.378).
Conclusions: Fatigue is prevalent among patients with IBS and commonly co-occurs with other symp-
toms. This is the ﬁrst study to fully examine fatigue in IBS, which shed light on the comprehensive
management of fatigue in this patient group. Future research is warranted to further explore fatigue-
related factors and underlying mechanisms of fatigue in IBS.
Copyright © 2016, Korean Society of Nursing Science. Published by Elsevier. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Irritable bowel syndrome (IBS) is the most common functional
gastrointestinal (GI) disorder diagnosed by Rome III criteria, which
was developed to classify IBS based on clinical symptoms [1]. The
worldwide prevalence of IBS in adults is between 9.0% and 23.5%
[2]. It affects about 22 million people in the United States, repre-
senting 14.0% of the U.S. population [3] and 2.9%e15.6% in Asian
countries [4]. Low-grade mucosal inﬂammation, microbiome, and
visceral hypersensitivity are commonly accepted mechanisms that
alter gut function and generate symptoms of IBS [5,6]. Common GIN, Biobehavioral Nursing and
ington, 5015, 19th Avenue NE,
ciety of Nursing Science. Publishedsymptoms are changes in bowel habits (e.g., constipation-
dominant, diarrhea-dominant, & mixed), abdominal pain, bloat-
ing, intestinal gas, distension, ﬂatulence, incomplete evacuation,
and urgency [1]. Non-GI symptoms, such as depression, anxiety and
fatigue, can co-occur with GI symptoms in IBS [7,8].
Symptoms of IBS could result in signiﬁcant direct costs (e.g.,
physician visits, diagnostic tests, and prescription, or over-the-counter
medication) and indirect costs [e.g., work absenteeism, diminished
health-related quality of life (HRQOL)] to patients and health care in-
dustries. Thebiggest causes of health care costs of patientswith IBSare
non-GI symptoms (e.g., fatigue, depression, anxiety) [9].
Among non-GI symptoms of IBS, Lackner and Gudleski [8] re-
ported that 60.0% of patients with IBS (N¼ 176) experienced fatigue
independent of other symptoms in IBS. In addition, fatigue ranks as
the thirdmost common [8] somatic complaint after abdominal pain
and frequent bowel movements in patients with IBS. Fatigue in IBSby Elsevier. This is an open access article under the CC BY-NC-ND license (http://
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extremeweariness, and a state of exhaustion [8,10]. Fatigue is likely
to interfere with work productivity, HRQOL, cost effectiveness, and
daily activity in this patient group [11]. Qualitative research has
shown that patients with IBS experience fatigue as multidimen-
sional, persistent symptoms with far-reaching consequences, and
report low HRQOL [10].
It is challenging to provide effective fatigue management for
patients with IBS because there is a lack of research and informa-
tion about fatigue compared to other IBS symptoms, such as
abdominal pain, diarrhea, constipation, and psychological distress
[8]. The characteristics of fatigue (i.e., prevalence, severity, related
factors) and overall health care burden of fatigue in IBS are un-
known [8]. In addition, deﬁnition and assessment of fatigue used in
IBS studies are not consistent. The underlying mechanisms remain
unclear, although one study demonstrated that low-grade inﬂam-
mation is related to fatigue in IBS [12].
Understanding the phenomenon of fatigue in IBS via systematic
review and meta-analyses can guide health care providers toward
having insight and knowledge for the consistent symptomFigure 1. Flow diagram preferred reporting items for systematic revdiagnosis and fatigue-speciﬁc management. Therefore, the aims of
this study are (a) to explore characteristics of fatigue in IBS via a
systematic review, and (b) to examine pooled frequency and
severity of fatigue as well as pooled correlations between related
factors and fatigue in IBS via meta-analyses.
Methods
Search strategies
A systematic literature searchwas conducted inMedline,Web of
Science, Scopus, EMBASE, PubMed, CINAHL, Cochrane Library, and
PsychINFO. Key words were “symptoms”, “fatigue”, “prevalence”,
and “frequency”, in combination with “irritable bowel syndrome”
and “correlates”, “etiology” and “pathophysiology”. The lists of
studies were published from January 1995 to July 2014. Other
eligible studies were also identiﬁed by searching the cited refer-
ences from obtained published studies. The screening procedure
was based on the Preferred Reporting Items for Systematic Reviews
and Meta Analyses ﬂow diagram [13] (Figure 1).iews and meta-analyses. Note. IBS ¼ irritable bowel syndrome.
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Studies were included if they met the following criteria: (a) the
literature was published between 1995 and 2014; (b) the research
report involved the frequency of fatigue; and (c) original and
observational or experimental. By contrast, studies were excluded if
they met the following criteria: (a) review papers or editorials, and
not original research articles; (b) not published in English; (c)
qualitative studies; (d) duplicated; and (e) no reported fatigue data.
Next, 498 studies were present in the database. Finally, this pro-
cedure resulted in a preliminary set of 134 full-text studies.
On closer examination of the 134 abstracts/full-text studies, a
ﬁnal 24 studies were selected for the systematic review. Among the
24 selected studies in this review, the data from 17 studies were
eligible for each meta-analysis of the pooled frequency, severity of
fatigue, and the pooled correlations between fatigue and related
factors. Of these, fatigue data were not reported in two studies.
Thus, two studies were excluded for the pooled frequency of fatigue
meta-analysis (Figure 1).Figure 2. Funnel plot of 15 studies for pooled frequency of fatigue: standard error by
logit event rate.
Table 2 Tests of Publication Bias.
Meta-analysis of fatigue
(no. of studies)
Begg's test Egger's test
Kendall's Ƭ p SE p
Pooled frequency (n ¼ 15)
.52 .672 1.32 .572
Pooled severity (n ¼ 8)
Fatigue Impact Scale (n ¼ 5) .24 .821 1.98 .777
Short Form-36 (n ¼ 3) .01 .985 2.45 .802
Pooled correlation-basedData extraction and quality assessment
Data were extracted based on numeric data, country, publica-
tion year, settings, sex, sample size, age, and study design. Sample
size was obtained by subtracting the number of nonresponders
from the total number of IBS participants recruited for the studies.
Selected studies were evaluated using methodological criteria used
in a previous study [14] (Table 1). This process resulted in quality
scores ranging from 0 to 19 points, and the qualifying scores for
applicable studies were 16 or above [14]. The two authors (C.J.H. &
G.S.Y.) independently extracted data, reviewed selected studies,
and evaluated the quality of studies. Disagreement was resolved
through consensus by a third party, a nursing professor. The
agreement rate to determine the reliability of the ratings was 97.6%,
and disagreements were adjusted through discussions.measure of effect size (n ¼ 4)
.21 .983 2.24 .962
Note. SE ¼ standard error.
Meta-analytical and statistical methods
Meta-analysis is useful to get more precise estimates of disease
frequencies, such as disease incidence rates, frequency proportions,
overall mean, and 95% conﬁdence interval (CI) [15,16]. Publication
bias was tested by funnel plot (Figure 2), Begg's test, and Egger's
test (Table 2). Heterogeneity was analyzed with Q statistics, in
which p < .10 was considered statistically signiﬁcant, and I2 sta-
tistics (I2 < 25.0%: no heterogeneity; I2 > 75.0%: high or extreme
heterogeneity). We primarily conducted meta-analysis for obtain-
ing the pooled frequency of fatigue in IBS. Considering heteroge-
neity of study characteristics, we showed the pooled frequency ofTable 1 Criteria to Evaluate Quality of Prevalence Studies: Criteria and Scoring.a
Representativeness of the target population
 At least one of the following should apply for the study: an entire target population, ra
irritable bowel syndrome (2-points); reasons for nonresponse described & nonrespo
 Response rate: > 90.0% (2 points), 70.0%e90.0% (1 point), < 70.0% (0 point).
Quality of data
 Were the data primarily from a prevalence study (2 points) or from a survey not sp
 The same mode of data collection should be the used for all subjects (2 points), if n
 The data collected directly from the patient by means of validated tools (3 points), no
(1 point).
General description of method & inclusion of prevalence of fatigue in results
 Description of the target population & setting where patients were found (2 points)
 Description of disease, sex, & age. All (2 points), two or three (1-point).
 Final sample size (1 point).
 Prevalence recall periods should be stated (1 point).
Note. aAdopted from Deandrea et al [14]. Copyright 2014 by U.S. Cancer Pain Relief Comfatigue by subgroup analyses (e.g., age, settings, & study design)
(Table 3). As well, metaregressionwas conducted for calculating the
relation of study characteristics to the pooled frequency of fatigue.
Independent variables for use in the logistic metaregression model
were selected, if p (between-studies) < .05 was met in study
characteristics listed in Table 3. Multicollinearity among indepen-
dent variables were examined using the variance inﬂation factor
(nonmulticollinearity: variance inﬂation factor < 10). Secondarily,ndomly selected sample, or sample started to represent the target population with
nders (2 points).
eciﬁcally designed for that purpose (1 point)?
ot (1 point).
validated tools (2 points), from proxies or retrospectively from the medical record
.
mittee.
Table 3 Heterogeneity Test for the Meta-Analysis: Pooled Frequency of Fatigue.
Study characteristics Sub-variables Studies
n
Frequency of fatiguea
% (95% CI)
Test for heterogeneity between & within-studies
Qdf Between p Between I
2 (%) Between I2 (%) Within
Total 15 54.2 (38.5, 69.4) 266.4214 .007 98.43 e
Country United States 7 54.4 (51.6, 57.1) 15.922 .321 32.72 87.43*
Europe 5 54.5 (52.2, 57.5) 98.12*
Asia 3 63.2 (60.4, 65.6) 92.34*
Publication year 1995e1999 1 57.8 (42.0, 72.0) 14.213 .458 29.84 e
2000e2004 3 61.3 (58.6, 63.9) 98.82*
2005e2009 4 53.9 (51.0, 56.5) 98.31*
2010e2014 7 53.9 (51.0, 55.5) 94.12*
Settings Primary health care 8 53.9 (50.6, 57.3) 21.831 .042 83.92 98.32*
Tertiary health care 7 58.5 (54.9, 60.9) 95.23*
Female prevalence  50.0% & < 70.0% 11 53.9 (50.6, 57.3) 59.241 .004 72.33 91.23*
 70.0% 4 56.8 (53.8, 59.6) 89.51*
Sample size of IBS n < 100 6 53.9 (50.6, 57.0) 8.712 .598 22.12 88.72*
100  n < 500 6 56.8 (53.8, 59.6) 86.41*
n  500 3 53.8 (50.2, 55.4) 77.62*
Mean age (yr) < 40 2 61.3 (58.6, 63.9) 42.422 .039 82.93 98.21*
 40 & < 50 9 53.9 (51.2, 56.3) 98.72*
 50 4 52.8 (50.2, 54.2) 98.41*
Study design Descriptive
Case control
12 53.9 (50.5, 57.1) 4.112 .783 13.41 98.52*
3 53.8 (51.2, 59.8) 99.74*
Note. CI ¼ conﬁdence interval; df ¼ degree of freedom; IBS ¼ irritable bowel syndrome.
*p < .05.
a Weighted effect size and standard error were applied, resulting in pooled frequency and 95% CIs.
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measured by the most frequently used fatigue tools across studies.
Lastly, a meta-analysis on correlation values was conducted to
examine the pooled correlations of fatigue with its related factors.
The frequency of fatigue in each study was expressed as the
number of cases divided by the total number of participants in the
original studies. The pooled frequency and severity of fatigue were
calculated with weighted effect size and standard errors, along
with 95% CI [15]. For the meta-analysis on correlation analysis,
correlation-based measure of effect size (rES) was obtained using
Fisher's z transformation [17]. A two-sided p < .05 was considered
statistically signiﬁcant. The statistical analyses were conducted
using Comprehensive Meta-Analysis 2.0 software (Biostat, Engle-
wood, NJ, USA).Results
This section consists of two parts. First, we provide a summary
of the systematic review regarding characteristics of fatigue, and
then we describe the results of meta-analysis of fatigue (pooled
frequency, severity & correlations) in IBS.Part 1. Systematic review
Characteristics of selected studies
A total of 24 studies were included for the systematic review
(Table 4). The average quality score of the 24 studies was 16.7
(range: 16e19) out of 19. The majority were descriptive studies
(n ¼ 20) and four were case control studies. The most frequently
used fatigue tools were Fatigue Impact Scale (FIS; n ¼ 5) [12,18e21]
and Short-Form 36 (SF-36; n ¼ 3) [22e24] to assess fatigue in pa-
tients with IBS. Only 5 of the 24 studies used the FIS as a validated
fatigue-speciﬁc tool [12,18e21]. In other studies, fatigue was eval-
uated using subitems of symptom diary or questionnaires. Half of
the studies were conducted in the US from 2010 to 2014, and at
both primary care and gastroenterology clinics. In most studies, the
mean ages of participants ranged from 40 years to 50 years, and
females accounted for 50.0%e70.0% of the participants.Deﬁnitions of fatigue
There were various deﬁnitions of fatigue in IBS across the
studies. Four deﬁnitions emerged from the IBS studies as follows:
(a) tiredness, (b) loss of vitality, (c) cognitive, physical, psycholog-
ical fatigue, and (d) disability (Table 4). “Tiredness” was the most
frequently used term in six studies [11,25e29], where the fatigue
was a state of exhaustion using a daily diary, a psychosomatic
checklist, and general interview. In ﬁve studies [8,22e24,30], fa-
tigue was deﬁned as “loss of vitality or lack of energy”; and in four
of the ﬁve studies, vitality scale of SF-36 [22e24] or SF-12 [8] were
used. In another ﬁve studies [12,18e21], fatigue was described as a
“cognitive, physical, and psychological fatigue” using FIS. Only Van
Oudenhove et al [31] deﬁned fatigue as a disability. Fatigue was not
speciﬁed, but described as mixed deﬁnitions in two studies that
combined loss of vitality, tiredness and emotional worn out [32,33].
Fatigue was not deﬁned in ﬁve studies [34e37]. In this review, it
turned out that there were a wide range of deﬁnitions. Interest-
ingly, deﬁnitions of fatigue in IBS seemed to be dependent on
assessment tools used.
Fatigue-related factors
GI symptoms. GI symptom, which is measured by summing
scores of abdominal pain, diarrhea, constipation, bloating, and
other GI discomforts, was identiﬁed as a frequently appearing
symptom associated with an increased level of fatigue in six studies
[8,19e21,26,33]. Of these, four studies speciﬁed that the severity of
abdominal pain was associated with fatigue [8,20,26,33]. Two
studies [11,24] reported that the frequency of fatigue differed by IBS
bowel pattern subtypes; however, the results were inconsistent
between the two studies. Spiegel et al [11] suggested fatigue was
the most common IBS-related extraintestinal symptom, in which
constipation-dominant IBS is 28.0%, diarrhea-dominant IBS is
15.0%, andmixed IBS is 9.0% (p < .05, N¼ 123). In contrast, Si, Wang,
Chen, Sun, and Dai [24] reported the opposite; they found that the
highest frequency of fatigue (78.3%) was reported in diarrhea-
dominant IBS and the lowest frequency in constipation-dominant
IBS (63.0%).
Psychological distress. Another most frequent factor related to
fatigue were psychological distress in six studies [8,30e32,34,38].
Table 4 Characteristics of Studies Included for Systematic Review and Meta-analyses (N ¼ 24).
First author,
yr & country
Design Settings Sample size,
(% of female)
Fatigue scale Frequency of
fatigue (%)
Fatigue-related factors Quality assessment
(0e19 point)
Fatigue as “tiredness”
aJarrett 2000 USA [27] Descriptive 3 N ¼ 82
(100.0%)
SCL-90
& daily diary
NA Female sex 16
Lustyk 2001 USA [29] Descriptive 1 N ¼ 54
(100.0%)
BDQ 74.0% Inactivity 16
aCain 2009 USA [25] Descriptive 3 N ¼ 187
(83.2%)
Daily diary NA Menstruating or
postmenopausal status
16
Kato 2010 USA [28] Descriptive 1 N ¼ 1,105
(56.3%)
General interview Idiopathic
chronic
fatigue (9.6%)
Comorbidity with chronic
fatigue syndrome (2.9%)
16
Spiegel 2010 USA [11] Descriptive 3 N ¼ 123
(73.2%)
IBS-Impact
Scale
26.0% Bowel pattern subtypes 17
aHeitkemper 2011 USA [26] Descriptive 3 N ¼ 166
(100.0%)
Daily diary NA IBS symptom severity,
abdominal pain
17
Fatigue as “loss of vitality (lack of energy)”
Hahn 1999 USA [23] Descriptive 1 N ¼ 500
(80.0%)
SF-36 40.0% Sleep disturbance,
lower energy,
interferences
in daily life
16
aGralnek 2000 USA [22] Descriptive 3 N ¼ 877
(67.3%)
SF-36 &
Self-report
NA Low HRQOL 16
Si 2004 China [24] Descriptive 1 N ¼ 662
(53.2%)
Symptom Questionnaire
& SF-36
72.7% Bowel pattern subtypes,
low HRQOL
16
Lee 2009 Hong Kong [30] Case control 3 N ¼ 127
(53.2%)
40-item
Questionnaire
79.8% Depression,
anxiety, stress
16
Lackner 2013 USA [8] Descriptive 3 N ¼ 176
(78.3%)
SF-12 60.8% IBS symptom severity,
abdominal pain, depression,
anxiety, stress, low HRQOL
19
Fatigue as “cognitive, physical, psychosocial fatigue”
Piche 2007 France [20] Descriptive 1 N ¼ 51
(80.0%)
FIS 62.7% IBS symptom severity,
abdominal pain, female sex,
Leptin
18
Pitche 2008 France [12] Descriptive 1 N ¼ 50
(80.0%)
FIS 60.0% Low-grade
inﬂammation
17
Simren 2008 Sweden [21] Case control 3 N ¼ 80
(63.2%)
FIS NA IBS symptom severity,
sleep disturbance,
female sex,
unstable employment
16
Piche 2010 France [19] Descriptive 3 N ¼ 40
(75.2%)
FIS 59.5% IBS symptom severity,
depression
18
Anty 2011 France [18] Descriptive 1 N ¼ 42
(75.1%)
FIS 55.0% Leptin,
low HRQOL
17
Fatigue as “disability”
Van Oudenhove 2011 Belgium [31] Descriptive 3 N ¼ 142
(75.3%)
Chronic Fatigue-like
Symptoms Questionnaire
56.0% Depression 17
Fatigue as mixed-deﬁnition with “loss of vitality/tiredness/emotional worn out”
Longstreth 2005 USA [32] Descriptive 1 N ¼ 155
(81.3%)
IBS-Impact Scale NA Emotional distress,
sleep disturbance,
interferences
in daily life,
low HRQOL,
eating habits
17
aWitthoft 2013 Germany [33] Descriptive 1 N ¼ 414
(54.3%)
PHQ-15 NA IBS symptom severity,
abdominal pain,
sleep disturbance
18
Fatigue not deﬁned
aDunlop 2003 England [34] Descriptive 3 N ¼ 28
(33.1%)
IBS-QOL Questionnaire NA Depression,
anxiety
16
Naliboff 2003 USA [36] Descriptive 3 N ¼ 42
(50.2%)
Validated
semantic differential
scales: 23 items of
current mood
98.7% Stress,
lower arousal ratings
16
Hamilton 2009 USA [35] Case control 1 N ¼ 4,388
(76.3%)
General interview 13.3% NA 19
aChang 2011 USA [37] Descriptive NA NA Stress Symptom Ratings NA Stress 16
Tang 2012 China [38] Case control 3 N ¼ 452
(57.1%)
IBS Symptom
Questionnaire
47.5% Depression, anxiety
female sex,
low HRQOL
17
Note. BDQ ¼ bowel disease questionnaire; F¼ female; FIS ¼ fatigue impact scale; HRQOL¼ health-related quality of life; IBS¼ irritable bowel syndrome; NA ¼ not addressed;
PHQ-15 ¼ patient health questionnaire-15; SCL-90 ¼ symptom checklist-90-revised; SF-36 ¼ short-form 36; 1 ¼ primary health care settings; 3 ¼ tertiary health care
settings.
a Denotes the studies excluded from meta-analyses (n ¼ 7).
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symptoms and comorbid with fatigue. Lackner and Gudleski [8]
showed that 41.6% of the variance predicting fatigue included
depression, anxiety and perceived stress in the regressionmodel. In
addition, stress was reported to be positively related to fatigue in
four studies [8,30,36,37].
Sleep disturbance. The next frequently appearing factor related
to fatigue in IBS was sleep disturbance as a co-occurring symptom
[21,23,32,33]. In particular, Witthoft et al [33] reported that fatigue
was positively related to poor sleep quality (r ¼ .29, p < .05,
N¼ 414). Simren et al [21] found that IBS patients with high fatigue
have more sleeping difﬁculties and “too little sleep”.
Biological factors. The severity of fatigue was greater in female
patients than male patients in four studies [20,21,27,38]. In addi-
tion, one study [36] reported that the higher arousal of central
processing of visceral stimuli was related to lower fatigue in IBS.
Indicators of low-grade inﬂammation played a role as fatigue-
related biomarkers [12,18,20]. Piche et al [12] demonstrated that
mast cell count, a marker of intestinal inﬂammation, was correlated
with fatigue (r¼ .64, p < .001, N¼ 50). Piche et al [20] and Anty et al
[18] reported that the leptin levels related to inﬂammation were
positively associated with fatigue in IBS. Other biomarkers of he-
moglobin (r ¼.19, p < .001, N ¼ 80) and albumin (r ¼ .15, p¼ .01,
N ¼ 80), were negatively correlated with the severity of fatigue;
however, no association was found between fatigue and C-reactive
protein or platelets in IBS [21].
Impact of fatigue. The HRQOL was the most frequently reported
factor in six studies as a possible consequence of fatigue in IBS.
Many studies reported that fatigue was signiﬁcantly inversely
correlated with low HRQOL scores, and emphasized the negative
impact of fatigue on HRQOL [8,18,22,24,32,38]. Two studies re-
ported that fatigue was associated with interferences in daily life
[23,32].
Others. Less frequently reported factors related to fatigue were
menstruating or postmenopausal status [25], inactivity [29], un-
stable employment [21], comorbidity with chronic fatigueFigure 3. Forest plot of pooled frequency of fatigue in IBS. Note. CI ¼ conﬁdence interval; IB
patients with irritable bowel syndrome. bTotal number of patients with irritable bowel synsyndrome [28], and eating habits [32]. Cain et al [25] found that the
level of fatigue was very high among women in menstruation and
women postmenopause in IBS. Lustyk et al [29] reported that
inactive patients with IBS had greater fatigue compared to active
patients with IBS. With regard to social and environmental aspects,
only Simren et al [21] reported that the employment status was
associated with fatigue. Patients who were unemployed, retired, or
on long-term sick leave had more severe fatigue than those who
were employed (p < .001), but living conditions, educational level
and marital status did not affect the severity of fatigue in IBS.
Part 2. Meta-analyses
Publication bias and test of heterogeneity
Begg's funnel plot (Figure 2) and Egger's test (Table 2) were
performed for meta-analysis. The shape of funnel plot was sym-
metrical and the results of Egger's test statistically supported the
result of the funnel plot. As a result, no publication biases were
present in any meta-analyses (Table 2). Q test and I2 statistical
analysis were tested to check for heterogeneity. High heterogene-
ities across studies were calculated for the pooled frequency of
fatigue (Table 3& Figure 3), the pooled severity of fatigue (Figure 4),
and the pooled correlations between fatigue and related factors
(Figure 5). Thus, random effect models were applied in each meta-
analysis (Figures 3, 4, & 5).
Pooled frequency of fatigue
Overall pooled frequency. A total of 15 studies were included for
meta-analysis of the pooled frequency of fatigue, with 2,096 cases
reporting fatigue out of 7,954 participants with IBS. The results of
the meta-analyses were reported in Table 3 and Figure 3. Table 3
showed the overall result and subgroup analyses (e.g., age, set-
tings, design, & year) of pooled frequency of fatigue with 95% CI.
The overall pooled frequency of fatigue in IBS was 54.2% [95% CI
(38.5, 69.4)], and high heterogeneity was observed (I2¼ 98.4%). The
frequency of fatigue ranged from 9.6% [28] to 98.7% [36].S ¼ irritable bowel syndrome. aTotal number of positive cases who reported fatigue in
drome. cNormal approximation of effect size with 95% CI.
Figure 4. Forest plot of pooled severity of fatigue in IBS. Note. CI ¼ conﬁdence interval; IBS ¼ irritable bowel syndrome.
Figure 5. Forest plot of correlation between HRQOL and the severity of fatigue in IBS. Note. CI ¼ conﬁdence interval; HRQOL ¼ health-related quality of life; IBS ¼ irritable bowel
syndrome; rES ¼ correlation-based measure of effect size. arES using Fisher's z transformation of r.
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frequency of fatigue signiﬁcantly differed by settings, female sex,
and age (Table 3). The frequency of fatigue at the tertiary health
care setting was 58.5% [95% CI (54.9, 60.9)], which was signiﬁcantly
higher than the frequency of fatigue at the primary health care
settings [53.9%, 95% CI (50.6, 57.3), p ¼ .042]. The frequency in the
“female 70.0% group” [56.8%, 95% CI (53.8, 59.6)] was signiﬁcantly
higher than in the “female ranged from 50.0% to 70.0% group”
[53.9%, 95% CI (50.6, 57.3), p ¼ .004]. The frequency of fatigue in the
“ 40 year-old group” was 61.3% [95% CI (58.6, 63.9)], which was
higher than that in the “41e50 year-old group” [53.9%, 95% CI (51.2,
56.3)] and the “ 51-year-old group” [52.8%, 95% CI (50.2, 54.2),
p ¼ .039].
Female sex, age, and settings were included as independent
variables in themultivariatemeta-regression analysis (Table 3). The
females were 3.3 times (b ¼ 3.3, p ¼ .023) more likely to report
fatigue than males were. Younger patients were 3.2 times (b ¼ 3.2,
p ¼ .012) more likely to report fatigue than older patients. The
frequency of fatigue reported at the tertiary care setting was 4.7
times (p¼ .015; data not shown) greater compared to the frequency
at the primary care settings.Pooled severity of fatigue
Figure 4 showed the pooled severity of fatigue measured by FIS
and SF-36-vitality scale, which were most frequently used tools
across studies. Our pooled FIS score was 58.2 out of 160 (0 signi-
fying “no problem”, 160 signifying “extreme problem”), indicating
the higher the score the greater the impact of fatigue [95% CI (34.3,
86.7)]. Our pooled SF-36 score was 43.9 [95% CI (26.9, 64.9)]. The
total score of the scale ranges from 0 which signiﬁes “low vitality”to 100 which signiﬁes “high vitality”. A lower score indicates a
higher degree of fatigue, and a score less than 60.9 in SF-36 was
interpreted as great severity of fatigue [39].Meta-analysis on correlations
To conduct meta-analysis, at least three studies are required
[15,16]. However, the available correlation values (r) of the majority
of related factors with fatigue (except for HRQOL) were less than
three from 17 studies. Thus, we were only able to obtain pooled
correlation (rES) between the severity of fatigue and HRQOL in four
studies [8,21,32,38]. The overall rES between the severity of fatigue
and HRQOLwas.378 in random effects model (p < .001; Figure 5).Discussion
This systematic review and meta-analysis provided an in-depth
overview of the existing literature to understand fatigue in IBS. We
reviewed characteristics of selected studies, fatigue instruments,
deﬁnitions of fatigue and factors related to fatigue in IBS; we also
conducted meta-analyses for the pooled frequency and severity of
fatigue, and correlations between fatigue and related factors.
To our knowledge, there is no research that clearly deﬁnes fa-
tigue in IBS; therefore, we could not specify the deﬁnition of fatigue
in IBS in the current literature. However, our study showed that
“tiredness” is the most commonly used term to describe fatigue in
IBS. The patterns of fatigue in IBS were mixed-types of acute and
chronic fatigue (duration > 6 months) [21,23]. Through this review,
patients with IBS showed a tendency similar to central fatigue, such
as mentally tired and physical fatigue (i.e., failure to initiate phys-
ical activity, lack of energy arising from central nervous system),
C.J. Han, G.S. Yang / Asian Nursing Research 10 (2016) 1e108not peripheral fatigue (i.e., muscle fatigue caused by disorders of
neuromuscular junction transmission), which could be related to
brain-gut axis interaction and cognitive psychological effect in IBS
[40].
This review examined the possible correlates with fatigue in
IBS, such as abdominal pain, psychological distress, and HRQOL.
Fatigue was mentioned as a signiﬁcant predictor of patients' low
HRQOL in many studies [8,18,22,24,32,38]. However, most of the
studies did not provide the correlation values (i.e., Pearson r), and
did not clearly state whether they adjusted confounders. In addi-
tion, there is a lack of studies that assess biological mechanisms,
self-efﬁcacy, self-coping, and social/environmental aspects of
fatigue.
The pooled frequency of fatigue (54.2%) in IBS, which was ac-
quired from our meta-analysis, was higher compared to the fre-
quency of fatigue in the U.S. population (37.9%, N ¼ 28,902 adults)
[38,41], in cancer patients (30.0%, N ¼ 6,125) [42], and in Parkin-
son's disease (33.8%, N ¼ 136) [43]. Hamilton et al [35] supported
our ﬁndings. They examined the odds ratio (OR) of fatigue in IBS,
and found that the odds of IBS patients with fatigue were 4.1 times
greater than that of the healthy control group [OR¼ 4.1, 95% CI (3.6,
4.7)].
Meta-regression with subgroup variables on the frequency of
fatigue showed signiﬁcantly positive relationships with tertiary
care settings, female sex, and younger age. The following reasons
may be accountable for these results: Patients who visited tertiary
health care settings are more likely to be ill and have severe dis-
eases and other comorbidities, compared to the patients who
visited primary health care settings. These comorbidities together
with complex and severely ill conditions may contribute to the
increased frequency of fatigue [44]. Also, females are more likely to
report symptoms than males do, and the diagnosis of IBS is more
likely to occur in young females (teens through their 40s) [45]. This
tendency may also contribute to sex-related and age-related dif-
ferences in the pooled frequency of fatigue in IBS across studies.
In our review, the ﬁndings showed that the severity of fatigue in
IBS is higher compared to that of populations with GI disorders,
cancer, or the general healthy population; however, it is lower
compared to that of those with chronic fatigue syndrome. The
pooled severity of fatigue in IBS (pooled FIS score ¼ 58.2) is rela-
tively high, when compared to non-IBS studies using FIS (M¼ 40.00
in 181 patients with Crohn's disease [46], M ¼ 54.5 in 108 patients
with primary biliary cirrhosis [47]); but our pooled FIS score was
lower than the score in 615 patients with chronic fatigue syndrome
(M ¼ 130.5) [48].
The pooled SF-36 vitality score in this review (M ¼ 43.9) indi-
cated high fatigue and low vitality (the lower the score, the higher
the fatigue) [39]. Among the non-IBS studies using SF-36, our result
was also relatively lower when compared to the fatigue in patients
with Crohn's disease (M ¼ 51.0, N ¼ 96) [49], with breast cancer
(M ¼ 46.0, N ¼ 430) [50], and in the general population after
adjusting for age, gender and education (M ¼ 60.0, N ¼ 2,214) [49].
However, our pooled SF-36 score was higher than the score in the
review paper of patients with chronic fatigue syndrome (M  35.0,
N ¼ 780 from 9 studies) [51].
The severity of fatiguewas shown to have a negatively moderate
linear relationship with HRQOL (rES ¼ .378), indicating that there
is a moderate effect of fatigue severity on HRQOL [17]. Because the
high severity of fatigue in IBS patients and its impact on the HRQOL
were presented in our analyses, a more comprehensive fatigue
assessment is necessary for understanding fatigue to provide
effective fatigue management in patients with IBS.
Although we obtained meaningful results regarding IBS-related
fatigue, there are several limitations to be addressed in this study.
First, this systematic review included all relevant studies of fatiguein IBS; however, nine studies were excluded because no frequency
or prevalence of fatigue data was available for meta-analysis. If we
have sufﬁcient publications for this review, we might present re-
sults that can be generalized by obtaining true frequency and
severity of fatigue. Second, this review only included published
studies; therefore, publication bias may be a possible limitation,
even though such a bias was not found in Begg's test and Egger's
test in our meta-analyses. Third, high heterogeneity was found in
study characteristics, such as gender, age, settings, and study
design, across the selected studies. Fourth, the included studies in
this review differed in the use of tools to measure fatigue. Sixteen
of the 24 studies used multisymptom fatigue measurements, such
as symptoms questionnaires and daily symptom diary. This
inconsistency of fatigue measurements may lead to a biased esti-
mation of fatigue in IBS. Taken together, the interpretations of our
results should be made cautiously. Lastly, all of the studies
measured variables at the same time, which does not allow the
inference of causal relationships between fatigue and related
factors.
Clinical implications
The ﬁndings from this systematic review and meta-analyses are
important in translating research into education and clinical prac-
tice for health care professionals. This work will inform health care
professionals (i.e., nurses, nurse practitioners, gastroenterologist)
about understanding fatigue as one of the major symptoms of IBS,
and have them be aware of comprehensive assessment and man-
agement of symptoms such as abdominal pain, psychological
distress, sleep quality, and HRQOL. “Tiredness” can be suggested as
a general deﬁnition of fatigue to assess fatigue in IBS. However, it
may be hard to describe fatigue with one deﬁnition in chronic
diseases such as IBS [8,21,52]. Thus, various deﬁnitions and tools of
fatigue shown in this review can be used to assess fatigue for IBS
patients. Qualitative data collection in clinical practice is needed for
better understanding of and describing fatigue and associated
symptom phenomena.
Furthermore, this study sheds light on future fatigue research in
this population. Further IBS studies with large samples are needed
to (a) test the psychometric properties of fatigue instruments, (b)
further explore fatigue, and its related factors using validated tools,
(c) examine causal relationships between fatigue and related fac-
tors, (d) identify underlyingmechanisms of fatigue, and (e) develop
further intervention study for managing fatigue.
Conclusion
This review is the ﬁrst to fully examine fatigue in IBS via a
systematic review and meta-analysis. This current review found
that “tiredness” is the most commonly used term to deﬁne fatigue
in IBS. GI symptom, psychological distress (depression & anxiety),
and HRQOL are the most frequently related factors with fatigue in
IBS. The pooled frequency and severity of fatigue in IBS via meta-
analysis were high. Tertiary health care settings, female sex, and
age were signiﬁcantly and positively associated with the pooled
frequency of fatigue in IBS. Among the fatigue-related factors,
HRQOL was shown to have a negative moderate relationship with
the severity of fatigue.
Conﬂicts of Interest
The authors declare no potential conﬂicts of interest with
respect to the research, authorship, and/or publication of this
article.
C.J. Han, G.S. Yang / Asian Nursing Research 10 (2016) 1e10 9Acknowledgement
We thank Dr. Jihye Jung (nursing professor) for her assistances
as a third party in data extraction and quality assessment, when
disagreements occurred between the authors.References
1. Drossman DA, Dumitrascu DL. Rome III: new standard for functional gastro-
intestinal disorders. J Gastrointestin Liver Dis. 2006;15(3):237e41.
2. International Foundation for Functional Gastrointestinal Disorders. Statistics of
IBS.Milwaukee (WI). Author; 2013 [cited 2015 Feb 26]. Available from: http://
www.aboutibs.org/site/what-is-ibs/facts/statistics
3. Hungin APS, Chang L, Locke GR, Dennis EH, Barghout V. Irritable bowel syn-
drome in the United States: prevalence, symptom patterns and impact. Aliment
Pharmacol Ther. 2005;21(11):1365e75.
http://dx.doi.org/10.1111/j.1365-2036.2005.02463.x
4. Gwee KA, Bak YT, Ghoshal UC, Gonlachanvit S, Lee OY, Fock KM, et al. Asian
consensus on irritable bowel syndrome. J Gastroenterol Hepatol. 2010;25(7):
1189e205. http://dx.doi.org/10.1111/j.1440-1746.2010.06353.x
5. Park H. [The pathophysiology of irritable bowel syndrome: inﬂammation and
motor disorder]. Korean J Gastroenterol. 2006;47(2):101e10. Korean.
6. Pimentel M, Lembo A, Schoenfeld P, Cash B. Irritable bowel syndrome: patho-
physiology andgoals of therapy.MedRoundtableGenMedEd. 2015;1(3):248e56.
7. Makhani M, Yang J, Mirocha J, Low K, Pimentel M. Factor analysis demonstrates
a symptom cluster related to methane and non-methane production in irritable
bowel syndrome. J Clin Gastroenterol. 2011;45(1):40e4.
http://dx.doi.org/10.1097/MCG.0b013e3181f423ea
8. Lackner JM, Gudleski GD, DiMuro J, Keefer L, Brenner DM. Psychosocial pre-
dictors of self-reported fatigue in patients with moderate to severe irritable
bowel syndrome. Behav Res Ther. 2013;51(6):323e31.
http://dx.doi.org/10.1016/j.brat.2013.03.001
9. Levy RL, Jones KR, Whitehead WE, Feld SI, Talley NJ, Corey LA. Irritable bowel
syndrome in twins: heredity and social learning both contribute to etiology.
Gastroenterol. 2001;121(4):799e804.
http://dx.doi.org/10.1053/gast.2001.27995
10. Håkanson C, Sahlberg-Blom E, Ternestedt B-M. Being in the patient position:
experiences of health care among people with irritable bowel syndrome. Qual
Health Res. 2010;20(8):1116e27.
http://dx.doi.org/10.1177/1049732310369914
11. Spiegel B, Bolus R, Agarwal N, Sayuk G, Harris L, Lucak S, et al. Measuring
symptoms in the irritable bowel syndrome: development of a framework for
clinical trials. Aliment Pharmacol Ther. 2010;32(10):1275e91.
http://dx.doi.org/10.1111/j.1365-2036.2010.04464.x
12. Piche T, Saint-Paul MC, Dainese R, Marine-Barjoan E, Iannelli A, Montoya ML,
et al. Mast cells and cellularity of the colonic mucosa correlated with fatigue
and depression in irritable bowel syndrome. Gut. 2008;57(4):468e73.
http://dx.doi.org/10.1136/gut.2007.127068
13. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for sys-
tematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med.
2009;151(4):264e9. http://dx.doi.org/10.1371/journal.pmed.1000097
14. Deandrea S, Corli O, Consonni D, Villani W, Greco MT, Apolone G. Prevalence of
breakthrough cancer pain: a systematic review and a pooled analysis of pub-
lished literature. J Pain Symptom Manag. 2014;47(1):57e76.
http://dx.doi.org/10.1016/j.jpainsymman.2013.02.015
15. Barendregt JJ, Doi SA, Lee YY, Norman RE, Vos T. Meta-analysis of prevalence.
J Epidemiol Community Health. 2013;67(11):974e8.
http://dx.doi.org/10.1136/jech-2013-203104
16. Hackett ML, Pickles K. Part I: frequency of depression after stroke: an updated
systematic review and meta-analysis of observational studies. Int J Stroke.
2014;9(8):1017e25. http://dx.doi.org/10.1111/ijs.12357
17. Cohen J. A power primer. Psychol Bull. 1992;112(1):155e9.
18. Anty R, Marjoux S, Bekri S, DeGalleani L, Dainese R, Gelsi E, et al. Plasma
carnitine is associated with fatigue in chronic hepatitis C but not in the irritable
bowel syndrome. Aliment Pharmacol Ther. 2011;33(8):961e8.
http://dx.doi.org/10.1111/j.1365-2036.2011.04608.x
19. Piche T, Ducrotte P, Sabate J, Cofﬁn B, Zerbib F, Dapoigny M, et al. Impact of
functional bowel symptoms on quality of life and fatigue in quiescent Crohn
disease and irritable bowel syndrome. Neurogastroenterol Motil. 2010;22(6).
http://dx.doi.org/10.1111/j.1365-2982.2010.01502.x, 626ee174.
20. Piche T, Huet PM, Gelsi E, Barjoan EM, Cherick F, Caroli-Bosc FX, et al. Fatigue in
irritable bowel syndrome: characterization and putative role of leptin. Eur J
Gastroenterol Hepatol. 2007;19(3):237e43.
http://dx.doi.org/10.1097/01.meg.0000252627.50302.b4
21. Simren M, Svedlund J, Posserud I, Bjornsson ES, Abrahamsson H. Predictors of
subjective fatigue in chronic gastrointestinal disease. Aliment Pharmacol Ther.
2008;28(5):638e47. http://dx.doi.org/10.1111/j.1365-2036.2008.03770.x
22. Gralnek IM, Hays RD, Kilbourne A, Naliboff B, Mayer EA. The impact of irritable
bowel syndrome on health-related quality of life. Gastroenterol. 2000;119(3):
654e60. http://dx.doi.org/10.1053/gast.2000.1648423. Hahn BA, Yan S, Strassels S. Impact of irritable bowel syndrome on quality of
life and resource use in the United States and United Kingdom. Digestion.
1999;60(1):77e81.
24. Si J, Wang L, Chen S, Sun L, Dai N. Irritable bowel syndrome consulters in
Zhejiang province: the symptoms pattern, predominant bowel habit subgroups
and quality of life. World J Gastroenterol. 2004;10(7):1059e64. http://
dx.doi.org/15052694.
25. Cain KC, Jarrett ME, Burr RL, Rosen S, Hertig VL, Heitkemper MM. Gender
differences in gastrointestinal, psychological, and somatic symptoms in irri-
table bowel syndrome. Digest Dis Sci. 2009;54(7):1542e9.
http://dx.doi.org/10.1007/s10620-008-0516-3
26. Heitkemper M, Cain KC, Shulman R, Burr R, Poppe A, Jarrett M. Subtypes of
irritable bowel syndrome based on abdominal pain/discomfort severity and
bowel pattern. Dig Dis Sci. 2011;56(7):2050e8.
http://dx.doi.org/10.1007/s10620-011-1567-4
27. Jarrett M, Heitkemper M, Cain KC, Burr RL, Hertig V. Sleep disturbance in-
ﬂuences gastrointestinal symptoms in women with irritable bowel syndrome.
Dig Dis Sci. 2000;45(5):952e9. http://dx.doi.org/10.1023/A:1005581226265
28. Kato K, Sullivan PF, Pedersen NL. Latent class analysis of functional somatic
symptoms in a population-based sample of twins. J Psychosom Res.
2010;68(5):447e53. http://dx.doi.org/10.1016/j.jpsychores.2010.01.010
29. LustykKM, JarrettME,Bennett JC, HeitkemperMM.Doesa physically active lifestyle
improve symptoms in womenwith irritable bowel syndrome?Gastroenterol Nurs.
2001;24(3):129e37. http://dx.doi.org/10.1097/00001610-200105000-00007
30. Lee S, Wu J, Ma Y, Tsang A, Guo WJ, Sung J. Irritable bowel syndrome is strongly
associated with generalized anxiety disorder: a community study.
Aliment Pharmacol Ther. 2009;30(6):643e51.
http://dx.doi.org/10.1111/j.1365-2036.2009.04074.x
31. Van Oudenhove L, Vandenberghe J, Vos R, Holvoet L, Tack J. Factors associated
with co-morbid irritable bowel syndrome and chronic fatigue-like symptoms
in functional dyspepsia. Neurogastroenterol Motil. 2011;23(6).
http://dx.doi.org/10.1111/j.1365-2982.2010.01667.x, 524ee202.
32. Longstreth GF, Bolus R, Naliboff B, Chang L, Kulich KR, Carlsson J, et al. Impact of
irritable bowel syndrome on patients' lives: development and psychometric
documentation of a disease-speciﬁc measure for use in clinical trials. Eur J
Gastroenterol Hepatol. 2005;17(4):411e20.
http://dx.doi.org/10.1097/00042737-200504000-00004
33. Witthoft M, Hiller W, Loch N, Jasper F. The latent structure of medically
unexplained symptoms and its relation to functional somatic syndromes.
Int J Behav Med. 2013;20(2):172e83.
http://dx.doi.org/10.1007/s12529-012-9237-2
34. Dunlop SP, Jenkins D, Neal KR, Spiller RC. Relative importance of enterochro-
mafﬁn cell hyperplasia, anxiety, and depression in postinfectious IBS.
Gastroenterology. 2003;125(6):1651e9.
http://dx.doi.org/10.1053/j.gastro.2003.09.028
35. Hamilton W, Gallagher A, Thomas J, White P. Risk markers for both chronic
fatigue and irritable bowel syndromes: a prospective case-control study in
primary care. Psychol Med. 2009;39(11):1913e21.
http://dx.doi.org/10.1017/S0033291709005601
36. Naliboff BD, Berman S, Chang L, Derbyshire SW, Suyenobu B, Vogt BA, et al.
Sex-related differences in IBS patients: central processing of visceral stimuli.
Gastroenterology. 2003;124(7):1738e47.
http://dx.doi.org/10.1016/S0016-5085(03)00400-1
37. Chang L. The role of stress on physiologic responses and clinical symptoms in
irritable bowel syndrome. Gastroenterology. 2011;140(3):761e5.
http://dx.doi.org/10.1053/j.gastro.2011.01.032
38. Tang YR, Yang WW, Wang YL, Lin L. Sex differences in the symptoms and
psychological factors that inﬂuence quality of life in patients with irritable
bowel syndrome. Eur J Gastroenterol Hepatol. 2012;24(6):702e7.
http://dx.doi.org/10.1097/MEG.0b013e328351b2c2
39. Ware JE, Kosinski M, Keller S. SF-36 physical and mental health summary
scales: a user's manual. Boston (MA): The Health Institute, New England
Medical Center; 1994.
40. Chaudhuri A, Behan PO. Fatigue in neurological disorders. Lancet.
2004;363(9413):978e88. http://dx.doi.org/10.1016/S0104-6736(04)15794-2
41. Ricci JA, Chee E, Lorandeau AL, Berger J. Fatigue in the US workforce: preva-
lence and implications for lost productive work time. J Occup Environ Med.
2007;49(1):1e10. http://dx.doi.org/10.1097/01.jom.0000249782.60321.2a
42. Curt GA. Impact of fatigue on quality of life in oncology patients.
Semin Hematol. 2000;37(4 Suppl 6):14e7.
http://dx.doi.org/10.1016/S0037-1963(00)90063-5
43. Stocchi F, Adagio I. Beneﬁts of treatment with rasagiline for fatigue symptoms
in patients with early Parkinson's disease. Eur J Neurol. 2014;21(2):357e60.
http://dx.doi.org/10.1111/ene.12205
44. Zielinski A, Håkansson A, Beckman A, Halling A. Impact of comorbidity on the
individual's choice of primary health care provider. Scand J Prim Health Care.
2011;29(2):104e9. http://dx.doi.org/10.3109/02813432.2011.562363
45. Chang L, Heitkemper MM. Gender differences in irritable bowel syndrome. Gas-
troenterol. 2002;123(5):1686e701. http://dx.doi.org/10.1053/gast.2002.36603
46. van Langenberg DR, Gibson PR. Factors associated with physical and cognitive
fatigue in patients with Crohn's disease: a cross-sectional and longitudinal
study. Inﬂamm Bowel Dis. 2014;20(1):115e25.
http://dx.doi.org/10.1097/01.MIB.0000437614.91258.70
C.J. Han, G.S. Yang / Asian Nursing Research 10 (2016) 1e101047. Jones DEJ, Bhala N, Burt J, Goldblatt J, Prince M, Newton JL. Four year follow up
of fatigue in a geographically deﬁned primary biliary cirrhosis patient cohort.
Gut. 2006;55(4):536e41. http://dx.doi.org/10.1136/gut.2005.080317
48. Blazquez A, Ruiz E, Aliste L, García-Quintana A, Alegre J. The effect of fatigue
and ﬁbromyalgia on sexual dysfunction in women with chronic fatigue syn-
drome. J Sex Marital Ther. 2015;41(1):1e10.
http://dx.doi.org/10.1080/0092623X.2013.864370
49. Høivik ML, Bernklev T, Solberg IC, Cvancarova M, Lygren I, Jahnsen J, et al.
Patients with Crohn's disease experience reduced general health and vitality in
the chronic stage: ten-year results from the IBSEN study. J Crohns Colitis.
2012;6(4):441e53. http://dx.doi.org/10.1016/j.crohns.2011.10.00150. Nieboer P, Buijs C, Rodenhuis S, Seynaeve C, Beex LVAM, van der Wall E, et al.
Fatigue and relating factors in high-risk breast cancer patients treated with
adjuvant standard or high-dose chemotherapy: a longitudinal study. J Clin
Oncol. 2005;23(33):8296e304. http://dx.doi.org/10.1200/jco.2005.10.167
51. Jason LA, Brown M, Evans M, Anderson V, Lerch A, Brown A, et al. Measuring
substantial reduction in functioning in patients with CFS. Disabil Rehabil.
2011;33(7):589e98. http://dx.doi.org/10.3109/09638288.2010.503256
52. Wagner D, Nisenbaum R, Heim C, Jones J, Unger E, Reeves W. Psychometric
properties of the CDC Symptom Inventory for assessment of chronic fatigue
syndrome. Popul Health Metr. 2005;3:8.
http://dx.doi.org/10.1186/1478-7954-3-8
